Peptides in the pipeline: How companies are overcoming the early-stage challenges
Much larger than traditional small molecule drugs, peptides enable rapid tissue penetration while retaining the selectivity and potency of a …
Post
-
-
US vaccine manufacturers set to lose as RFK pushes for weaker vaccine mandates
Earlier this year, the Trump Administration, backed by US Health and Human Services Secretary Robert F Kennedy (RFK) Jr, a …
-
FDA homes in on biosimilar accessibility in new draft guidance
The US Food and Drug Administration (FDA) has further updated its regulatory framework around biosimilar medicines in a bid to …
-
Building for decades: Dubai’s long game in life sciences
Editor's note: This feature was reported in part prior to the escalation of hostilities in the Gulf, when Iran launched …
-
Junshi receives China’s NMPA acceptance for toripalimab injection
Junshi Biosciences has received acceptance from China’sNational Medical Products Administration (NMPA) for toripalimab subcutaneous injection (JS001sc) new drug applications (NDAs) …
-
Novo and Hims & Hers become partners to end legal feud
Novo Nordisk and Hims & Hers have come to an agreement that will see the telehealth company sell Novo’s branded …
-
NewcelX and Eledon partner for NCEL-101 programme
NewcelX has signed a collaborative research agreement with Eledon Pharmaceuticals to advance its NCEL-101 programme for type 1 diabetes (T1D). The …
-
GlobalData’s key thoughts from World EPA Congress 2026
GlobalData Healthcare recently attended the World Evidence, Pricing and Access (EPA) congress in Amsterdam on 3-4 March 2026. This conference …
-
GSK sells liver disease drug candidate to Alfasigma for $690m
Alfasigma has agreed to buy the global rights to GSK’s experimental liver disease drug in a deal worth up to …
-
Vinay Prasad to leave the FDA again
Vinay Prasad is once again set to depart from his role at the US Food and Drug Administration (FDA), after …
-
Sciwind secures China’s NMPA approval for Ecnoglutide injection
Sciwind Biosciences has received China’s National Medical Products Administration (NMPA) approval for its Ecnoglutide injection for chronic weight management. Ecnoglutide is …
-
BMS gains FDA approval for Sotyktu in psoriatic arthritis treatment
Bristol Myers Squibb (BMS) has received the US Food and Drug Administration (FDA) approval for Sotyktu (deucravacitinib), an oral selective …
-
Multiple Myeloma Awareness Month: the current and future landscape
March is Multiple Myeloma (MM) Awareness Month, which raises awareness, action, and amplifies the voices of individuals impacted by MM, …
-
Women first: the Gulf’s new healthcare blueprint
Nabta Health, a Dubai-based women's health company, is up for a prestigious MedTech award, but its founder Sophie Smith has …
-
Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal
Alnylam Pharmaceuticals has forged a discovery collaboration worth up to $1.23bn with cardiovascular disease specialist, Tenaya Therapeutics. Through this partnership, Alnylam …
